This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Lead Discovery Center Gmbh, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 1,335 
Years Active: 2024
Title: Innovations by Elena Sabrina Reckzeh in Glucose Transporter Inhibition
Introduction
Elena Sabrina Reckzeh, an accomplished inventor based in Dortmund, Germany, stands out in the realm of pharmaceutical innovations. Her contributions significantly enhance the understanding of glucose transporters, which play a crucial role in various metabolic functions.
Latest Patents
Elena holds a notable patent focusing on "Inhibitors of glucose transporters (GLUTs)." This invention pertains to 2,6-methanobenzo[g][1]oxacin-4-one compounds, their analogs, and pharmaceutically acceptable salts. These compounds have been identified as selective inhibitors of glucose transporters 1 and 3 (GLUTs 1 and 3). The patent outlines methods for preparing these compounds and emphasizes their potential as active agents in the prophylaxis and treatment of metabolic and immunological diseases, autoimmune diseases, inflammation, graft versus host disease, cancer, and related metastasis. Additionally, it details pharmaceutical compositions that include these innovative compounds.
Career Highlights
Elena's career is marked by her involvement with prominent organizations such as Lead Discovery Center GmbH and the Max Planck Society for the Advancement of Science (Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.). Her work in these institutions has allowed her to navigate the complex landscape of pharmaceutical research and innovation.
Collaborations
Throughout her career, Elena has collaborated with esteemed professionals, including Herbert Waldmann and Gunther Zischinsky. These partnerships have fostered a rich environment for innovation, leading to impactful discoveries and advancements in the pharmaceutical field.
Conclusion
Elena Sabrina Reckzeh's impressive patent regarding glucose transporters highlights her significant contributions to the medical and pharmaceutical industries. Her innovative work not only showcases her expertise but also has the potential to influence the future of treatments for various diseases, establishing her as a remarkable inventor in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile